Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Rawlings Goss, Renata A ^a   Campbell, Michael C ^a,b   Tishkoff, Sarah A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

African genetic diversity; Biomarkers; Cancer; Diabetes; Disease susceptibility; miRNA; Population differentiation; Whole genome sequencing

Indexed keywords

MESSENGER RNA; TUMOR MARKER;

ALLELE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOMICS; HUMAN; INTERNATIONAL COOPERATION; INVERTED REPEAT; METABOLISM; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS;

ALLELES; BREAST NEOPLASMS; CONSERVED SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOMICS; HUMANS; INTERNATIONALITY; INVERTED REPEAT SEQUENCES; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84908009066     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-53     Document Type: Article

References (83)

1. MicroRNA and cancer. Jansson MD, Lund AH, Mol Oncol 2012 6 6 590 610 10.1016/j.molonc.2012.09.006 23102669
2. Most mammalian mRNAs are conserved targets of microRNAs. Friedman RC, Farh KK, Burge CB, Bartel DP, Genome Res 2009 19 1 92 105 18955434
3. Population differences in microRNA expression and biological implications. Huang RS, Gamazon ER, Ziliak D, Wen Y, Im HK, Zhang W, Wing C, Duan S, Bleibel WK, Cox NJ, Dolan ME, RNA Biol 2011 8 4 692 701 10.4161/rna.8.4.16029 21691150
4. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Lewis BP, Burge CB, Bartel DP, Cell 2005 120 1 15 20 10.1016/j.cell.2004.12.035 15652477
5. Impact of microRNA regulation on variation in human gene expression. Lu J, Clark AG, Genome Res 2012 22 7 1243 1254 10.1101/gr.132514.111 22456605
6. Expression of Arabidopsis MIRNA genes. Xie Z, Allen E, Fahlgren N, Calamar A, Givan SA, Carrington JC, Plant Physiol 2005 138 4 2145 2154 10.1104/pp.105.062943 16040653
7. Joint analysis of miRNA and mRNA expression data. Muniategui A, Pey J, Planes FJ, Rubio A, Brief Bioinform 2013 14 3 263 278 10.1093/bib/bbs028 22692086
8. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Huntzinger E, Izaurralde E, Nat Rev Genet 2011 12 2 99 110 10.1038/nrg2936 21245828
9. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Chekulaeva M, Filipowicz W, Curr Opin Cell Biol 2009 21 3 452 460 10.1016/j.ceb.2009.04.009 19450959
10. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Flynt AS, Lai EC, Nat Rev Genet 2008 9 11 831 842 10.1038/nrg2455 18852696
11. Gene regulation by transcription factors and microRNAs. Hobert O, Science 2008 319 5871 1785 1786 10.1126/science.1151651 18369135
12. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Filipowicz W, Bhattacharyya SN, Sonenberg N, Nat Rev Genet 2008 9 2 102 114 18197166
13. Getting to the root of miRNA-mediated gene silencing. Eulalio A, Huntzinger E, Izaurralde E, Cell 2008 132 1 9 14 10.1016/j.cell.2007.12.024 18191211
14. Phylogenetic shadowing and computational identification of human microRNA genes. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E, Cell 2005 120 1 21 24 10.1016/j.cell.2004.12.031 15652478
15. miRBase: tools for microRNA genomics. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, Nucleic Acids Res 2008 36 Database issue 154 D158 17991681
16. Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies. Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP, PLoS Pathog 2013 9 7 1003484 10.1371/journal.ppat.1003484 23874201
17. MicroRNAs in human cancer. Farazi TA, Hoell JI, Morozov P, Tuschl T, Adv Exp Med Biol 2013 774 1 20 10.1007/978-94-007-5590-1-1 23377965
18. Clinical applications for microRNAs in cancer. Nana-Sinkam SP, Croce CM, Clin Pharmacol Ther 2013 93 1 98 104 10.1038/clpt.2012.192 23212103
19. Circulating microRNAs as Disease Markers in Pediatric Cancers. Chicago ARHLCsHo, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2012 Available from: http://clinicaltrials.gov/show/NCT01541800:NLM Identifier: NCT01541800
20. Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation. Florida UoS, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2012 Available from: http://clinicaltrials.gov/show/NCT01631760:NLM Identifier: NCT01631760
21. Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia. Group CsO, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2010 Available from: http://clinicaltrials.gov/show/NCT01057199:NLM Identifier: NCT01057199
22. Circulating microRNAs as Biomarkers of Sepsis. Hospital C, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2000 [cited 2002 Feb 27] 2009, Available from: http://clinicaltrials.gov/show/NCT00862290:NLM Identifier: NCT00862290
23. Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes (Lymphoscreen). Hospital NU, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2012 Available from: http://clinicaltrials.gov/show/NCT01042301:NLM Identifier:NCT01042301
24. Micro-RNA Expression Profiles in High Risk Prostate Cancer. Hospital WU, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2010 Available from: http://clinicaltrials.gov/show/NCT01220427:NLM Identifier: NCT01220427
25. Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes. IRCCS CSdS, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2012 Available from: http://clinicaltrials.gov/show/NCT01334684:NLM Identifier:NCT01334684
26. Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer. Party ELCW, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2009 Available from: http://clinicaltrials.gov/show/NCT00864266:NLM Identifier: NCT00864266
27. Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer (MIRHO). Regaud IC, ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2012 Available from: http://clinicaltrials.gov/show/NCT01612871:NLM Identifier: NCT01612871
28. Expression of circulating microRNAs in patients with bladder urothelial carcinoma. Zhang ZC, Huang Y, Wang XJ, Wang M, Ma LL, Beijing Da Xue Xue Bao 2013 45 4 532 536 23939156
29. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E, Lung Cancer 2013 81 3 388 396 10.1016/j.lungcan.2013.05.007 23756108
30. Circulating miRNAs as potential marker for pulmonary hypertension. Wei C, Henderson H, Spradley C, Li L, Kim IK, Kumar S, Hong N, Arroliga AC, Gupta S, PLoS One 2013 8 5 64396 10.1371/journal.pone.0064396 23717609
31. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. Zhi F, Cao X, Xie X, Wang B, Dong W, Gu W, Ling Y, Wang R, Yang Y, Liu Y, PLoS One 2013 8 2 56718 10.1371/journal.pone.0056718 23437222
32. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu YY, Hu YY, Liu P, Huang S, Su SB, World J Gastroenterol 2012 18 37 5188 5196 23066312
33. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC, Int J Cancer 2012 130 6 1378 1386 10.1002/ijc.26153 21544802
34. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S, PLoS One 2010 5 10 13735 10.1371/journal.pone.0013735 21060830
35. Africa: continent of genome contrasts with implications for biomedical research and health. Ramsay M, FEBS Lett 2012 586 18 2813 2819 10.1016/j.febslet.2012.07.061 22858376
36. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Campbell MC, Tishkoff SA, Annu Rev Genomics Hum Genet 2008 9 403 433 10.1146/annurev.genom.9.081307.164258 18593304
37. Genetic structure in African populations: implications for human demographic history. Lambert CA, Tishkoff SA, Cold Spring Harb Symp Quant Biol 2009 74 395 402 10.1101/sqb.2009.74.053 20453204
38. The genetic structure and history of Africans and African Americans. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM, Science 2009 324 5930 1035 1044 10.1126/science.1172257 19407144
39. Evolutionary history and adaptation from high-coverage whole-genome sequences of diverse African hunter-gatherers. Lachance J, Vernot B, Elbers CC, Ferwerda B, Froment A, Bodo JM, Lema G, Fu W, Nyambo TB, Rebbeck TR, Zhang K, Akey JM, Tishkoff SA, Cell 2012 150 3 457 469 10.1016/j.cell.2012.07.009 22840920
40. Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project. Mu XJ, Lu ZJ, Kong Y, Lam HY, Gerstein MB, Nucleic Acids Res 2011 39 16 7058 7076 10.1093/nar/gkr342 21596777
41. Signatures of purifying and local positive selection in human miRNAs. Quach H, Barreiro LB, Laval G, Zidane N, Patin E, Kidd KK, Kidd JR, Bouchier C, Veuille M, Antoniewski C, Quintana-Murci L, Am J Hum Genet 2009 84 3 316 327 10.1016/j.ajhg.2009.01.022 19232555
42. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y, Cancer Epidemiol Biomarkers Prev 2013 22 3 327 336 10.1158/1055-9965.EPI-12-1131-T 23334589
43. Complete Khoisan and Bantu genomes from southern Africa. Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, Harris RS, Petersen DC, Zhao F, Qi J, Alkan C, Kidd JM, Sun Y, Drautz DI, Bouffard P, Muzny DM, Reid JG, Nazareth LV, Wang Q, Burhans R, Riemer C, Wittekindt NE, Moorjani P, Tindall EA, Danko CG, Teo WS, Buboltz AM, Zhang Z, Ma Q, Oosthuysen A, et al. Nature 2010 463 7283 943 947 10.1038/nature08795 20164927
44. dbSNP: the NCBI database of genetic variation. Sherry STWM, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K, Nucleic Acids Res 2001 29 1 308 311 10.1093/nar/29.1.308 11125122
45. Interrogating a high-density SNP map for signatures of natural selection. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD, Genome Res 2002 12 12 1805 1814 10.1101/gr.631202 12466284
46. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Zheng Q, Wang XJ, Nucleic Acids Res 2008 36 Web Server issue 358 W363 18487275
47. miRGator v2.0: an integrated system for functional investigation of microRNAs. Cho S, Jun Y, Lee S, Choi HS, Jung S, Jang Y, Park C, Kim S, Kim W, Nucleic Acids Res 2011 39 Database issue 158 D162 21062822
48. Genetic variation in microRNA networks: the implications for cancer research. Ryan BM, Robles AI, Harris CC, Nat Rev Cancer 2010 10 6 389 402 10.1038/nrc2867 20495573
49. Evidence for positive selection on a number of MicroRNA regulatory interactions during recent human evolution. Li J, Liu Y, Xin X, Kim TS, Cabeza EA, Ren J, Nielsen R, Wrana JL, Zhang Z, PLoS Genet 2012 8 3 1002578 10.1371/journal.pgen.1002578 22457636
50. Variation in genes required for normal mitosis and risk of breast cancer. Olson JE, Wang X, Goode EL, Pankratz VS, Fredericksen ZS, Vierkant RA, Pharoah PD, Cerhan JR, Couch FJ, Breast Cancer Res Treat 2010 119 2 423 430 10.1007/s10549-009-0386-1 19377877
51. Vital signs: racial disparities in breast cancer severity - United States, 2005-2009. (CDC) CfDCaP, MMWR Morb Mortal Wkly Rep 2012 61 45 922 926 23151952
52. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PW, Yao JC, Feig BW, Results from the National Cancer Data Base. Cancer 2008 113 3 461 469
53. Global ovarian cancer health disparities. Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM, Gynecol Oncol 2012 129 1 258 264 23266352
54. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI, Cancer 2011 117 18 4277 4285 10.1002/cncr.25969 21387261
55. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA, PLoS One 2012 7 1 29770 10.1371/journal.pone.0029770 22242178
56. The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and Cancer Risk: Evidence from Published Studies. He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, Chen L, Song G, Gao T, Li R, Wang S, PLoS One 2012 7 11 49032 10.1371/journal.pone.0049032 23155448
57. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, Griffiths LR, Cancer Genomics Proteomics 2012 9 3 115 118 22593246
58. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR, Twin Res Hum Genet 2011 14 5 417 421 10.1375/twin.14.5.417 21962133
59. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, Cheng X, Hsiao M, Hung MC, Cancer Res 2010 70 12 5096 5108 10.1158/0008-5472.CAN-09-4148 20501832
60. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, Yu AM, Biochem Pharmacol 2011 81 6 783 792 10.1016/j.bcp.2010.12.018 21219875
61. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, Xu Z, Miao Y, Br J Cancer 2010 103 4 567 574 10.1038/sj.bjc.6605724 20628378
62. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW, Chen YH, Jan Y, Hsiao M, Chang TY, Liu YH, Jeng YM, Wu CH, Huang MT, Su YH, Hung MC, Chien MH, Chen CY, Kuo ML, Su JL, Oncogene 2012 32 4 431 443 22410781
63. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Kim YW, Kim EY, Jeon D, Liu JL, Kim HS, Choi JW, Ahn WS, Drug Des Devel Ther 2014 8 293 314 24591819
64. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF, Cell 2012 151 5 1068 1082 10.1016/j.cell.2012.10.028 23142051
65. Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Long Q, Johnson BA, Osunkoya AO, Lai YH, Zhou W, Abramovitz M, Xia M, Bouzyk MB, Nam RK, Sugar L, Stanimirovic A, Williams DJ, Leyland-Jones BR, Seth AK, Petros JA, Moreno CS, Am J Pathol 2011 179 1 46 54 10.1016/j.ajpath.2011.03.008 21703393
66. A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM, BMC Genomics 2011 12 504 10.1186/1471-2164-12-504 21995669
67. Prioritization of genetic variants in the microRNA regulome as functional candidates in genome-wide association studies. Bulik-Sullivan B, Selitsky S, Sethupathy P, Hum Mutat 2013 34 8 1049 1056 10.1002/humu.22337 23595788
68. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, Dahl F, Fernandez A, Staker B, Pant KP, Baccash J, Borcherding AP, Brownley A, Cedeno R, Chen L, Chernikoff D, Cheung A, Chirita R, Curson B, Ebert JC, Hacker CR, Hartlage R, Hauser B, Huang S, Jiang Y, Karpinchyk V, et al. Science 2010 327 5961 78 81 10.1126/science.1181498 19892942
69. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L, Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB, Hood L, Galas DJ, Science 2010 328 5978 636 639 10.1126/science.1186802 20220176
70. A second generation human haplotype map of over 3.1 million SNPs. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, et al. Nature 2007 449 7164 851 861 10.1038/nature06258 17943122
71. Defining and providing robust controls for microRNA prediction. Ritchie W, Gao D, Rasko JE, Bioinformatics 2012 28 8 1058 1061 10.1093/bioinformatics/bts114 22408193
72. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002 19167326
73. Accurate microRNA target prediction correlates with protein repression levels. Maragkakis M, Alexiou P, Papadopoulos GL, Reczko M, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, Simossis VA, Sethupathy P, Vergoulis T, Koziris N, Sellis T, Tsanakas P, Hatzigeorgiou AG, BMC Bioinformatics 2009 10 295 10.1186/1471-2105-10-295 19765283
74. On the number of segregating sites in genetical models without recombination. Watterson GA, Theor Popul Biol 1975 7 2 256 276 10.1016/0040-5809(75)90020-9 1145509
75. Covariances of relatives stemming from a population undergoing mixed self and random mating. Cockerham CC, Weir BS, Biometrics 1984 40 1 157 164 10.2307/2530754 6733226
76. Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Holsinger KE, Weir BS, Nat Rev Genet 2009 10 9 639 650 10.1038/nrg2611 19687804
77. MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Cho S, Jang I, Jun Y, Yoon S, Ko M, Kwon Y, Choi I, Chang H, Ryu D, Lee B, Kim VN, Kim W, Lee S, Nucleic Acids Res 2013 41 Database issue 252 D257 23193297
78. A Catalog of Published Genome-Wide Association Studies. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, Manolio TA, Available at: http://www.genome.gov/gwastudies Accessed July 2013
79. A new statistical method for haplotype reconstruction from population data. Stephens M, Smith NJ, Donnelly P, Am J Hum Genet 2001 68 4 978 989 10.1086/319501 11254454
80. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 2 263 265 10.1093/bioinformatics/bth457 15297300
81. Gene ontology: tool for the unification of biology. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G, The Gene Ontology Consortium. Nat Genet 2000 25 1 25 29
82. REVIGO summarizes and visualizes long lists of gene ontology terms. Supek F, Bosnjak M, Skunca N, Smuc T, PLoS One 2011 6 7 21800 10.1371/journal.pone.0021800 21789182
83. Gephi: an open source software for exploring and manipulating networks. Bastian M, Heymann S, Jacomy M, International AAAI Conference on Weblogs and Social Media 2009 Available at: https://gephi.org/